Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lenz Therapeutics, Inc. (LENZ) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lenz Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1815776.
Total stock buying since 2021: $24,201,317.
Total stock sales since 2021: $50,574,726.
Total stock option exercises since 2021: $61,012.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 1,524,984 | $50,574,726 | 5,600 | $7,280 |
| 2024 | 1,032,529 | $15,551,154 | 0 | $0 | 48,333 | $53,732 |
| 2022 | 650,134 | $3,738,893 | 0 | $0 | 0 | $0 |
| 2021 | 420,310 | $4,911,270 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 448,807 | $17,715,472 | 0 | $0 |
| 2025-07 | 0 | $0 | 191,376 | $6,506,784 | 0 | $0 |
| 2025-06 | 0 | $0 | 884,801 | $26,352,470 | 0 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 1,400 | $2,912 |
| 2025-03 | 0 | $0 | 0 | $0 | 4,200 | $4,368 |
| 2024-12 | 0 | $0 | 0 | $0 | 3,333 | $6,932 |
| 2024-07 | 0 | $0 | 0 | $0 | 45,000 | $46,800 |
| 2024-05 | 34,520 | $551,079 | 0 | $0 | 0 | $0 |
| 2024-03 | 998,009 | $15,000,075 | 0 | $0 | 0 | $0 |
| 2022-04 | 429,464 | $1,751,118 | 0 | $0 | 0 | $0 |
| 2022-01 | 220,670 | $1,987,775 | 0 | $0 | 0 | $0 |
| 2021-12 | 22,329 | $227,532 | 0 | $0 | 0 | $0 |
| 2021-11 | 201,685 | $2,047,102 | 0 | $0 | 0 | $0 |
| 2021-10 | 196,296 | $2,636,636 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-26 | Versant Ventures Vii Gp-gp, Llc | Sale | 70,811 | 39.24 | 2,778,482 |
| 2025-08-25 | Versant Ventures Vii Gp-gp, Llc | Sale | 78,237 | 39.72 | 3,107,808 |
| 2025-08-22 | Versant Ventures Vii Gp-gp, Llc | Sale | 39,046 | 40.31 | 1,573,944 |
| 2025-08-18 | Versant Ventures Vii Gp-gp, Llc | Sale | 45,713 | 38.56 | 1,762,738 |
| 2025-08-15 | Versant Ventures Vii Gp-gp, Llc | Sale | 215,000 | 39.50 | 8,492,500 |
| 2025-07-10 | Versant Ventures Vii Gp-gp, Llc | Sale | 191,376 | 34.00 | 6,506,784 |
| 2025-06-27 | Versant Ventures Vii Gp-gp, Llc | Sale | 200,000 | 30.46 | 6,093,000 |
| 2025-06-20 | Versant Ventures Vii Gp-gp, Llc | Sale | 234,801 | 30.30 | 7,114,470 |
| 2025-06-18 | Versant Ventures Vii Gp-gp, Llc | Sale | 100,000 | 29.95 | 2,995,000 |
| 2025-06-10 | Versant Ventures Vii Gp-gp, Llc | Sale | 350,000 | 29.00 | 10,150,000 |
| 2025-04-09 | Olsson Shawn (Chief Commercial Officer) | Option Ex | 1,400 | 2.08 | 2,912 |
| 2025-03-07 | Schimmelpennink Evert B. (President, CEO and Secretary) | Option Ex | 4,200 | 1.04 | 4,368 |
| 2024-12-16 | Olsson Shawn (Chief Commercial Officer) | Option Ex | 3,333 | 2.08 | 6,932 |
| 2024-07-22 | Schimmelpennink Evert B. (President, CEO and Secretary) | Option Ex | 45,000 | 1.04 | 46,800 |
| 2024-05-14 | Chevallard Daniel R. (Chief Financial Officer) | Buy | 3,188 | 15.68 | 49,987 |
| 2024-05-13 | Mccollum James W (Director) | Buy | 31,332 | 15.99 | 501,092 |
| 2024-03-21 | Shah Rajeev M. | Buy | 998,009 | 15.03 | 15,000,075 |
| 2022-04-12 | Akkaraju Srinivas (10% Owner) | Buy | 350,000 | 4.08 | 1,428,000 |
| 2022-04-11 | Gutry Phil (CHIEF BUSINESS OFFICER) | Buy | 5,000 | 4.01 | 20,050 |
| 2022-04-11 | Akkaraju Srinivas (10% Owner) | Buy | 74,464 | 4.07 | 303,068 |
| 2022-01-24 | Akkaraju Srinivas (10% Owner) | Buy | 23,000 | 8.70 | 200,099 |
| 2022-01-21 | Akkaraju Srinivas (10% Owner) | Buy | 100,000 | 8.99 | 899,000 |
| 2022-01-20 | Akkaraju Srinivas (10% Owner) | Buy | 43,105 | 8.92 | 384,496 |
| 2022-01-19 | Akkaraju Srinivas (10% Owner) | Buy | 54,565 | 9.24 | 504,180 |
| 2021-12-15 | Akkaraju Srinivas (10% Owner) | Buy | 22,329 | 10.19 | 227,532 |
| 2021-11-22 | Akkaraju Srinivas (10% Owner) | Buy | 201,685 | 10.15 | 2,047,102 |
| 2021-10-15 | Akkaraju Srinivas (10% Owner) | Buy | 2,300 | 12.49 | 28,727 |
| 2021-10-14 | Akkaraju Srinivas (10% Owner) | Buy | 3,100 | 12.50 | 38,750 |
| 2021-10-13 | Akkaraju Srinivas (10% Owner) | Buy | 45,400 | 13.22 | 600,188 |
| 2021-10-08 | Akkaraju Srinivas (10% Owner) | Buy | 75,000 | 13.12 | 983,999 |
| 2021-10-07 | Akkaraju Srinivas (10% Owner) | Buy | 9,021 | 14.94 | 134,773 |
| 2021-10-06 | Akkaraju Srinivas (10% Owner) | Buy | 61,475 | 13.83 | 850,199 |
Insider trading activities including stock purchases, stock sales, and option exercises of LENZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lenz Therapeutics, Inc. (symbol LENZ, CIK number 1815776) see the Securities and Exchange Commission (SEC) website.